Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

4
results for

"Depression"

Article category

Keywords

Publication year

"Depression"

Research Letter

Depression and suicide-related events associated with tenofovir use in chronic hepatitis B: A pharmacovigilance analysis
You Deng, Wenya Chen, Weina Lu, Chao Sun, Wen Xie
Clin Mol Hepatol 2026;32(3):e320-e325.
Published online March 25, 2026
DOI: https://doi.org/10.3350/cmh.2026.0210
  • 1,426 View
  • 152 Download

Original Article

Global prevalence of depression and anxiety in patients with hepatocellular carcinoma: Systematic review and meta-analysis
Darren Jun Hao Tan, Sabrina Xin Zi Quek, Jie Ning Yong, Adithya Suresh, Kaiser Xuan Ming Koh, Wen Hui Lim, Jingxuan Quek, Ansel Tang, Caitlyn Tan, Benjamin Nah, Eunice Tan, Taisei Keitoku, Mark D. Muthiah, Nicholas Syn, Cheng Han Ng, Beom Kyung Kim, Nobuharu Tamaki, Cyrus Su Hui Ho, Rohit Loomba, Daniel Q. Huang
Clin Mol Hepatol 2022;28(4):864-875.
Published online July 25, 2022
DOI: https://doi.org/10.3350/cmh.2022.0136
Background/Aims
Depression and anxiety are associated with poorer outcomes in patients with hepatocellular carcinoma (HCC). However, the prevalence of depression and anxiety in HCC are unclear. We aimed to establish the prevalence of depression and anxiety in patients with HCC.
Methods
MEDLINE and Embase were searched and original articles reporting prevalence of anxiety or depression in patients with HCC were included. A generalized linear mixed model with Clopper-Pearson intervals was used to obtain the pooled prevalence of depression and anxiety in patients with HCC. Risk factors were analyzed via a fractional-logistic regression model.
Results
Seventeen articles involving 64,247 patients with HCC were included. The pooled prevalence of depression and anxiety in patients with HCC was 24.04% (95% confidence interval [CI], 13.99–38.11%) and 22.20% (95% CI, 10.07–42.09%) respectively. Subgroup analysis determined that the prevalence of depression was lowest in studies where depression was diagnosed via clinician-administered scales (16.07%;95% CI, 4.42–44.20%) and highest in self-reported scales (30.03%; 95% CI, 17.19–47.01%). Depression in patients with HCC was lowest in the Americas (16.44%; 95% CI, 6.37–36.27%) and highest in South-East Asia (66.67%; 95% CI, 56.68–75.35%). Alcohol consumption, cirrhosis, and college education significantly increased risk of depression in patients with HCC.
Conclusions
One in four patients with HCC have depression, while one in five have anxiety. Further studies are required to validate these findings, as seen from the wide CIs in certain subgroup analyses. Screening strategies for depression and anxiety should also be developed for patients with HCC.

Citations

Citations to this article as recorded by  Crossref logo
  • Treatment-related differences in quality of life and psychological distress among patients with hepatocellular carcinoma: A cross-sectional analysis
    Yi-Tseng Tsai, Zan-Ting Lu, Hsin-Yu Kuo, Ya-Han Yang, Yi-Jing Tsai, Kun Feng Tsai, Wen-Chun Liu
    Palliative and Supportive Care.2026;[Epub]     CrossRef
  • The multiorgan crosstalk network of the liver-brain axis: From molecular mechanisms to emerging therapeutic targets
    Wen-Tao Wang, Yuan-Yuan Xin, Jun-Qiang Niu, Wei-Lin Jin
    Molecular Aspects of Medicine.2026; 108: 101460.     CrossRef
  • Quality of life in patients with hepatocellular carcinoma: a bibliometric analysis
    Can Huang, Meng Chen, Yanfang Sun, Lin Zhang, Wei Liu
    Discover Oncology.2026;[Epub]     CrossRef
  • Anxiety, depression, and quality of life in hepatocellular carcinoma treated with drug-eluting microspheres plus lenvatinib: A prospective study
    Jian-Yu Liu, Zhi-Hui Liang, Jing-Lei Liu, Liang Li, Bao Cui, Tie-Gang Li
    World Journal of Psychiatry.2026;[Epub]     CrossRef
  • TRIM13 Suppressed the Proliferation and Migration of Hepatocellular Carcinoma Cells by Inducing Autophagy
    Longxu Jiang, Danghui Lu, Kristian Holgersson, Shan Zhang, Guangyan Shi, Laszlo Szekely, Xue Bai, Yuanpeng Zhai, Xinju Chen, Takahiro Seki, Kun Li
    Journal of Biochemical and Molecular Toxicology.2026;[Epub]     CrossRef
  • The effect of the PERMA model-based positive psychological intervention on the positive and negative emotions of patients with primary cancer undergoing hepatectomy
    Jieping Ying, Yingchun Cheng, Haiyan Huang, Yueqin Wang
    Journal of Psychosocial Oncology.2026; : 1.     CrossRef
  • Implementing sustainable liver health in Europe: a second EASL–Lancet Commission
    Tom H Karlsen, Sharon J Hutchinson, Shira Zelber-Sagi, Patrizia Carrieri, Francesco Negro, Aaron G Lim, Michele Cecchini, M Ashworth Dirac, Frank Murray, Eivind Engebretsen, Erika Duffell, Georg Schomerus, Kristin Voigt, Petter Bae Brandtzaeg, Alienor Ler
    The Lancet.2026; 407(10541): 1825.     CrossRef
  • Chronic stress disrupts hepatic homeostasis and accelerates liver cancer progression through ADRB2 signaling
    Huimin Qin, Liuwei Chu, Xiaying Zheng, Huimei Zhang, Yue Lan, Ji Hu, Lu Li
    Science Advances.2026;[Epub]     CrossRef
  • Joint latent profiles of death anxiety and treatment adherence in HCC patients
    Shoupeng Sheng, Lipeng Bai, Zhaxi Yundan, Hongwei Chen, Basang ZhaXi, LuoBu Duoji, Yi Shu, Xiaoqing Cao
    Frontiers in Psychiatry.2026;[Epub]     CrossRef
  • Multi-omics integration identifies cell-type-specific CISD1 and QDPR as druggable regulators linking hepatocellular carcinoma and major depressive disorder
    Longyang Sun, Junjie Bi, Jianguang Sun
    Psychiatry Research.2026; 364: 117277.     CrossRef
  • Psychological Stress Associated Bile Acid Reprogramming Promotes Hepatocellular Carcinoma Progression
    Ruijiang Zeng, Mengmeng Wang, Kang Wang, Zhuo Xing, Yulong Hong, Tongtong Li, Geng Zong, Chong Yang, Dan Zhang, Zhangling Chen, Xin Jin
    Advanced Science.2026;[Epub]     CrossRef
  • Association between emotional distress and efficacy of immune checkpoint inhibitors in patients with hepatocellular carcinoma: a multicentre, prospective observational study protocol
    Lin Ye, Jiaye Liao, Kangqiang Lin, Xuanting Chen, Yuanying Su, Hao Shi, Tao Wang, Qingrong Mo, Jun Weng, Renjian Li, Zhao Jiang, Yaqun Yu
    BMJ Open.2026; 16(7): e110148.     CrossRef
  • Symptom Cluster Trajectories Among Patients With Hepatocellular Carcinoma After Partial Hepatectomy: A Longitudinal Study
    Yanxiu Cai, Jing Li, Liuna Bi, Linlin Wang, Jing Han
    Journal of Clinical Nursing.2025; 34(10): 4166.     CrossRef
  • Is Health Status in Patients With Chronic Disorders of the Gastrointestinal System Disease‐Specific? Results From an Integral Approach
    Anja H. W. M. Lemlijn‐Slenter, Luuk P. van Iperen, Karolina A. P. Wijnands, Nico Wolter, Angelique E. de Rijk, Ad A. M. Masclee
    Neurogastroenterology & Motility.2025;[Epub]     CrossRef
  • Greater Symptom Burden and Poorer Quality of Life Outcomes Are Associated With The Co-Occurrence of Anxiety and Depression During Cancer Chemotherapy
    Alejandra Calvo-Schimmel, Marilyn J. Hammer, Yvette P. Conley, Steven M. Paul, Bruce A. Cooper, Joosun Shin, Carolyn Harris, Lisa Morse, Jon D. Levine, Christine Miaskowski
    Seminars in Oncology Nursing.2025; 41(2): 151809.     CrossRef
  • Paeoniflorin inhibits chronic restraint stress-induced progression of hepatocellular carcinoma through suppressing norepinephrine-induced activation of hepatic stellate cells via SRC/AKT/ERK pathways
    Yujun Luo, Wanfu Lin, Shuang Xiang, Yuanrong Shi, Meihuan Fu, Xiaofeng Zhai, Changquan Ling, Binbin Cheng
    Journal of Ethnopharmacology.2025; 344: 119517.     CrossRef
  • Global research trends on gastrointestinal cancer and mental health (2004–2024): a bibliographic study
    Wenjin Han, Tianmeng Wang, Zhiqiang He, Caihua Wang, Zhaozhao Hui, Shuangyan Lei, Nan Hao, Ning Li, Xiaoqin Wang
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Global prevalence and determinant factors of pain, depression, and anxiety among cancer patients: an umbrella review of systematic reviews and meta-analyses
    Addisu Getie, Manay Ayalneh, Melaku Bimerew
    BMC Psychiatry.2025;[Epub]     CrossRef
  • Management of Advanced Hepatocellular Carcinoma: A Review and Practical Guide
    Vishnu Nagalapuram, Niveditha Popuri, Ryan D. Nipp, Susanna V. Ulahannan, Kelsey S. Lau-Min
    JCO Oncology Practice.2025; 21(9): 1247.     CrossRef
  • Depressive symptoms and immune depletion in Chinese patients with advanced hepatocellular carcinoma: a multicentre study on their correlation
    Yan Zhang, Wei Zhou, Zhiping Ma, Zutao Chen, Naiping Li, Xiaomin Zhu, Yunhai Yao
    General Psychiatry.2025;[Epub]     CrossRef
  • Factors influencing anxiety and depression in advanced hepatocellular carcinoma patients and their impact on quality of life
    Maher Hendi, Bin Zhang, Jie-Min Lv, Xiu-Jun Cai
    World Journal of Psychiatry.2025;[Epub]     CrossRef
  • Sini Powder Alleviates Stress Response and Suppresses Hepatocellular Carcinoma Development by Restoring Gut Microbiota
    Si Mei, Zhe Deng, Fan-ying Meng, Qian-qian Guo, He-yun Tao, Lin Zhang, Chang Xi, Qing Zhou, Xue-fei Tian
    Chinese Journal of Integrative Medicine.2025; 31(9): 802.     CrossRef
  • Nervous system in hepatocellular carcinoma: Correlation, mechanisms, therapeutic implications, and future perspectives
    Wenxuan Li, Jinghao Zhang, Yueqiu Gao, Xiaoni Kong, Xuehua Sun
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2025; 1880(3): 189345.     CrossRef
  • Molecular mechanisms and clinical value of the correlation between depression and cancer
    Yuxiao Chen, Yafei Lu, Siyi Chen, Pengyi Liu, Junzhe He, Lingxi Jiang, Jun Zhang
    Medical Oncology.2025;[Epub]     CrossRef
  • Pyrimidinetrione benzodioxol ameliorates MAFLD-induced liver tumorigenesis and mood disorders in mice
    Fang-Yu Hsu, Wan-Chun Chiu, Fat-Moon Suk, Chun-Ya Lee, Ming-Hua Hsu, Yi-Jen Liao
    npj Gut and Liver.2025;[Epub]     CrossRef
  • Educational, financial, logistical, emotional, and social needs among patients with hepatocellular carcinoma
    Debbiesiu L. Lee, Sophia Hon, Daniela Prieto Bello, Lucia Fernandez, Patricia D. Jones
    Hepatology Communications.2025;[Epub]     CrossRef
  • Ansofaxine Hydrochloride inhibits hepatocellular carcinoma growth and enhances targeted therapy through the EGFR/MAPK pathway
    Yongfei He, Qiang Tao, Shutian Mo, Meifeng Chen, Jicai Wang, Hang Zhai, Shengjie Hong, Qiang Gao, Guangquan Zhang, Chuangye Han, Xianjie Shi
    Frontiers in Oncology.2025;[Epub]     CrossRef
  • The impact of graded nursing interventions based on quantitative risk assessment on psychological stress responses in patients undergoing resection for primary liver cancer
    Li Zhang, Xiaochao Ren, Luping Xu, Siming Zheng, Qinhong Xu
    BMC Nursing.2025;[Epub]     CrossRef
  • The Factors Influencing Quality of Life Among Patients With Hepatobiliary and Pancreatic Cancers
    Sunhee Hwang, Jieun Lee, Junglyun Kim
    Western Journal of Nursing Research.2025; 47(11): 1025.     CrossRef
  • Psychisches Befinden bei PatientInnen mit Leberzellkarzinom
    Karen Rischmüller, Veronika Kakouz, Martin Philipp, Theresia Blattmann, Georg Lamprecht, Susanne Singer
    Die Onkologie.2025; 31(12): 1202.     CrossRef
  • Association between olanzapine and immune function in lung cancer patients with anxiety and depression: a retrospective cohort study of medical records
    Shang Chen, Guizhong Huang, Sen Lei, Xiaojun Lin
    Frontiers in Psychiatry.2025;[Epub]     CrossRef
  • The prevalence of anxiety and depression in cancer around the world: An overview of systematic reviews evaluating 128 meta-analyses
    Javier Martinez-Calderon, Cristina García-Muñoz, Alberto Marcos Heredia-Rizo, Francisco Javier Cano-García
    Journal of Affective Disorders.2024; 351: 701.     CrossRef
  • Psychiatric disorders in patients with hepatocellular carcinoma: A large US cohort of commercially insured individuals
    Mausam J. Patel, Alex Jones, Yue Jiang, Prajwal Gowda, Lisa B. VanWagner, Thomas G. Cotter, Karim Seif El Dahan, Jeremy Louissaint, Madhukar Patel, Nicole E. Rich, Amit G. Singal, Sarah R. Lieber
    Alimentary Pharmacology & Therapeutics.2024; 60(4): 469.     CrossRef
  • The relationship between social determinants of health and neurocognitive and mood-related symptoms in the primary brain tumor population: A systematic review
    Macy L Stockdill, Amanda King, Morgan Johnson, Zuena Karim, Diane Cooper, Terri S Armstrong
    Neuro-Oncology Practice.2024; 11(3): 226.     CrossRef
  • Social short video platform assisted care for adverse psychological symptoms in cancer patients: A mixed‐methods study
    Shen Li, Xia Liu, Xia Wang, Yilin Wang, Xuelei Ma
    MedComm – Future Medicine.2024;[Epub]     CrossRef
  • Chronic stress influences the macrophage M1-M2 polarization balance through β-adrenergic signaling in hepatoma mice
    Juanjuan Yang, Wei Wei, Shuqun Zhang, Wei Jiang
    International Immunopharmacology.2024; 138: 112568.     CrossRef
  • Palliative care in patients with hepatocellular carcinoma: Results from a survey among hepatologists and palliative care physicians
    Massimo Iavarone, Lorenzo Canova, Eleonora Alimenti, Alessio Aghemo, Diego Taveggia, Gino Gobber, Giuseppe Cabibbo, Simone Veronese, Vincenza Calvaruso, Luciano Orsi, Paolo Caraceni, Pietro Lampertico
    Palliative Medicine.2024; 38(9): 1033.     CrossRef
  • Associations of tumor-related psychiatric symptoms and healthy behaviors with dynamic quality of life after hepatocellular carcinoma hepatectomy
    Feng-Juan Zhao, Rong-Rui Huo, Fan-Rong Li, Xue-Mei You
    Supportive Care in Cancer.2024;[Epub]     CrossRef
  • Systemic Connective Tissue Disease and Neuromyelitis Optica Spectrum Disorder Coexistence: A Systematic Review and Meta-Analysis
    Jessica Elisabetta Esposito, Giovanni Annoni, Milena D’Amato, Alessandra Graziosi, Francesca Troilo, Annalisa Di Risio, Gilda Angelini, Caterina Castiglione, Pierluigi Tocco, Paola Volpe, Giancarlo Di Iorio, Giustino Parruti, Ennio Polilli
    Journal of Integrative Neuroscience.2024;[Epub]     CrossRef
  • Barriers to palliative care in hepatocellular carcinoma: A review of the literature
    Mostafa Abasseri, Shakira Hoque, BA Slavica Kochovska, Kim Caldwell, Linda Sheahan, Amany Zekry
    Journal of Gastroenterology and Hepatology.2023; 38(7): 1047.     CrossRef
  • Correspondence on Letter 1 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”
    Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng
    Clinical and Molecular Hepatology.2023; 29(3): 821.     CrossRef
  • An offline to online cognitive behavioral stress management caring program effectively improves psychological pressure, spiritual well-being, and quality of life in postoperative hepatocellular carcinoma patients
    Yueping Liu, Meiling Sun
    Clinics and Research in Hepatology and Gastroenterology.2023; 47(8): 102195.     CrossRef
  • Combined Administration of Escitalopram Oxalate and Nivolumab Exhibits Synergistic Growth-Inhibitory Effects on Liver Cancer Cells through Inducing Apoptosis
    Vincent Chin-Hung Chen, Shao-Lan Huang, Jing-Yu Huang, Tsai-Ching Hsu, Bor-Show Tzang, Roger S. McIntyre
    International Journal of Molecular Sciences.2023; 24(16): 12630.     CrossRef
  • The Mediating Effect of Resilience on the Relationship Between Symptom Burden and Anxiety/Depression Among Chinese Patients with Primary Liver Cancer After Liver Resection
    Xue Zhang, Haoran Zhang, Zonghao Zhang, Hua Fan, Shuwen Li
    Patient Preference and Adherence.2023; Volume 17: 3033.     CrossRef
  • 15,428 View
  • 219 Download
  • 44 Web of Science
  • Crossref

Editorial

Liver fibrosis, cirrhosis, and portal hypertension

A need for patient-centered care in managing patients with liver cirrhosis
Eileen L. Yoon
Clin Mol Hepatol 2021;27(2):270-272.
Published online January 27, 2021
DOI: https://doi.org/10.3350/cmh.2021.0001

Citations

Citations to this article as recorded by  Crossref logo
  • The Impact of Oral Health-Related Quality of Life and Country-Level Context on Patients with Cirrhosis: a cross-sectional study
    Janaina B. Medina, Amanda dos Santos Matioli, Maria Gabriela Haye Biazevic , Edgard Michel-Crosato , Alba Pérez-Jardón , Juliana B. Franco, Mario Pérez-Sayáns , Karem López Ortega
    Revista Española de Enfermedades Digestivas.2026;[Epub]     CrossRef
  • The rise of non-invasive tools in the diagnosis of portal hypertension: Validation of the Baveno VII consensus
    Jeong-Ju Yoo, Sang Gyune Kim
    Clinical and Molecular Hepatology.2023; 29(1): 102.     CrossRef
  • Correspondence on Letter 1 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”
    Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng
    Clinical and Molecular Hepatology.2023; 29(3): 821.     CrossRef
  • 8,119 View
  • 132 Download
  • 2 Web of Science
  • Crossref
Original Article

Liver fibrosis, cirrhosis, and portal hypertension

Association between new-onset liver cirrhosis and suicide risk in South Korea: A nationwide cohort study
Suk-Yong Jang, Woo Sun Rou, Seok Hyun Kim, Byung Seok Lee, Hyuk Soo Eun
Clin Mol Hepatol 2021;27(2):283-294.
Published online December 3, 2020
DOI: https://doi.org/10.3350/cmh.2020.0227
Background/Aims
Current evidence suggests that liver cirrhosis (LC) causes severe psychological stress and depression, which are risk factors for suicide. Although previous studies reported the association between LC and suicidal thoughts, little is known of its effect on suicidal deaths. Therefore, this study was undertaken to investigate the effect of new-onset LC on suicide.
Methods
From the National Health Insurance Service-National Sample Cohort of South Korea, 5,809 incident LC patients and 11,618 risk-set controls matched by propensity score were selected for follow-up. The incidence rate of suicide was estimated using a generalized estimating equation with a Poisson distribution. Effect size was presented as a hazard ratio (HR) using Cox’s proportional hazards model.
Results
The incidence rate of suicide was 143.3 cases per 100,000 person years (95% confidence interval [CI], 100.2–205.1) among the LC cohort. The LC patients were 2.37 times more likely to commit suicide compared with matched controls (HR, 2.37; 95% CI, 1.44–3.88). Increased suicide risk was evident within the first 2 years of the follow-up period (HR, 2.59; 95% CI, 1.20–5.60) and among the 18–49-year-old age group (HR, 3.72; 95% CI, 1.45–9.56).
Conclusions
Our study found increased risk of suicide in patients with new onset LC, especially during the early period following diagnosis and in younger patients. To decrease this suicide risk, a regular and continuous social support system is required.

Citations

Citations to this article as recorded by  Crossref logo
  • Suicide mortality trends among cancer patients in Taiwan: suicide prevention efforts and cancer care improvements
    Bo-Yu Hsiao, Chun-Ju Chiang, Ya-Wen Yang, Wen-Chung Lee
    American Journal of Epidemiology.2026; 195(3): 807.     CrossRef
  • Impact of gastrectomy on the risk of alcohol-associated liver disease in patients with gastric cancer
    Sang Yi Moon, Yang Hyun Baek, Dongwoo Kang, Jungkuk Lee, Yeo Wool Kang, Minkook Son, Hongqun Liu, Samuel S. Lee, Junho Park
    Scientific Reports.2026;[Epub]     CrossRef
  • Association between the coronavirus disease pandemic and antipsychotic drug prescriptions among patients with dementia
    Kyungduk Hurh, Hyunkyu Kim, Eun-Cheol Park
    Journal of Alzheimer's Disease Reports.2026;[Epub]     CrossRef
  • Mediating effect of coping style between family resilience and demoralization in patients with decompensated cirrhosis
    Haixia Gao, Gang Mao, Shanshan Yin, Jianhua Niu, Ran Ding, Lei Liu
    Scientific Reports.2026;[Epub]     CrossRef
  • Suicide mortality in metabolic dysfunction–associated liver diseases: a nationwide cohort study
    Chaiho Jeong, Kyu-Na Lee, Dae Jong Oh, Soon Kyu Lee, Chang Wook Kim, Kyungdo Han, Mee Kyoung Kim
    Annals of Medicine.2026;[Epub]     CrossRef
  • An examination of the association between physical health conditions and lifetime suicide attempts
    Joanna Bhaskaran, Jordana L. Sommer, Natalie Mota, James M. Bolton, Jitender Sareen, Renée El-Gabalawy
    Journal of Psychosomatic Research.2026; 211: 112937.     CrossRef
  • Lower incidence of hepatocellular carcinoma with tenofovir alafenamide in chronic hepatitis B: Evidence from a large-scale cohort
    Hye-Jin Yoo, Jae-Young Kim, Jeong-Ju Yoo, Hye Won Lee, Sang Gyune Kim, Young Seok Kim
    JHEP Reports.2025; 7(2): 101268.     CrossRef
  • Depression and anxiety management in cirrhosis
    Paula C. Zimbrean, Simona S. Jakab
    Hepatology Communications.2025;[Epub]     CrossRef
  • Association Between Triglyceride/High-Density Lipoprotein Ratio and Incidence Risk of Heart Failure: A Population-Based Cohort Study
    Yoon-Kyung Chang, Ju-Young Park, Tae-Jin Song
    Journal of Clinical Medicine.2025; 14(3): 950.     CrossRef
  • Low-density lipoprotein cholesterol and clinical outcomes in patients with liver cirrhosis: a nationwide cohort study
    Byung Sik Kim, Jiyeong Kim, Nayeon Choi, Hyun-Jin Kim, Jeong-Hun Shin
    Annals of Medicine.2025;[Epub]     CrossRef
  • Understanding the Role of Palliative Care Within Routine Care of Advanced Liver Disease
    Simone A. Jarrett, Edward Bley, Richard S. Kalman
    Current Hepatology Reports.2024; 23(3): 307.     CrossRef
  • Comparative Interrupted Time Series Analysis of Direct Medical Expense and Length of Stay in Elderly Patients with Femoral Neck Fractures Who Underwent Total Hip Arthroplasty and Hemiarthroplasty: A Real World Nationwide Database Study
    Seung-Hoon Kim, Suk-Yong Jang, Yonghan Cha, Bo-Yeon Kim, Hyo-Jung Lee, Gui-Ok Kim
    Clinics in Orthopedic Surgery.2024; 16(2): 217.     CrossRef
  • Stigmatization of drinking patients with liver cancer: The role of socioeconomic status
    Camille Auriol, Patrick Raynal, Nicole Cantisano
    Heliyon.2024; 10(7): e29105.     CrossRef
  • Comparative Interrupted Time Series Analysis of Medical Expenses in Patients with Intertrochanteric Fracture Who Underwent Internal Fixation and Hemiarthroplasty
    Seung-Hoon Kim, Yonghan Cha, Suk-Yong Jang, Bo-Yeon Kim, Hyo-Jung Lee, Gui-Ok Kim
    Hip & Pelvis.2024; 36(2): 144.     CrossRef
  • Impact of long-term care insurance on medical costs and utilization by patients with Parkinson's disease
    Seung Hoon Kim, Eun-Cheol Park, Suk-Yong Jang
    Social Science & Medicine.2023; 317: 115563.     CrossRef
  • Risk of injuries before and after a diagnosis of cirrhosis: A population-based cohort study
    Ying Shang, Qing Shen, Elliot B. Tapper, Axel Wester, Hannes Hagström
    Hepatology Communications.2023;[Epub]     CrossRef
  • Development of Open-Angle Glaucoma in Adults With Seropositive Rheumatoid Arthritis in Korea
    Seung Hoon Kim, Sung Hoon Jeong, Hyunkyu Kim, Eun-Cheol Park, Suk-Yong Jang
    JAMA Network Open.2022; 5(3): e223345.     CrossRef
  • AASLD Practice Guidance: Palliative care and symptom‐based management in decompensated cirrhosis
    Shari S. Rogal, Lissi Hansen, Arpan Patel, Nneka N. Ufere, Manisha Verma, Christopher D. Woodrell, Fasiha Kanwal
    Hepatology.2022; 76(3): 819.     CrossRef
  • Association between new-onset Parkinson’s disease and suicide risk in South Korea: a nationwide cohort study
    Sung Hoon Jeong, Seung Hoon Kim, Doo Woong Lee, Eun-Cheol Park, Suk-Yong Jang
    BMC Psychiatry.2022;[Epub]     CrossRef
  • A need for patient-centered care in managing patients with liver cirrhosis
    Eileen L. Yoon
    Clinical and Molecular Hepatology.2021; 27(2): 270.     CrossRef
  • 10,983 View
  • 218 Download
  • 20 Web of Science
  • Crossref